Western blot analysis showed the decreased expression of synaptic proteins (e.g., PSD-95 and GluA1) in the PFC from ABX-treated mice after FMT from RA patients compared to FMT from HCs (Fig. 2H, I). The gene discussed is GRIA1; the disease is rheumatoid arthritis.